ID

15070

Beschrijving

A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants; ODM derived from: https://clinicaltrials.gov/show/NCT02343783

Link

https://clinicaltrials.gov/show/NCT02343783

Trefwoorden

Versies (1)
  1. 14-05-16 14-05-16 -
Geüploaded op

14 mei 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Dermatitis, Atopic NCT02343783

Engels

Eligibility Dermatitis, Atopic NCT02343783

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
participant must have signed an informed consent document prior to any study related procedures indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study
Beschrijving

Informed Consent | Comprehension Study Protocol

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0162340
UMLS CUI [2,2]
C2348563
participant must be willing/able to adhere to the study visit schedule and other requirements, prohibitions and restrictions specified in this protocol
Beschrijving

Compliance behavior Study Protocol

Datatype

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C2348563
* for participants with asthma:
Beschrijving

Study Subject | Asthma

Datatype

boolean

Alias
UMLS CUI [1]
C0681850
UMLS CUI [2]
C0004096
participant must have a physician documented diagnosis of asthma for at least 12 months before screening
Beschrijving

Asthma

Datatype

boolean

Alias
UMLS CUI [1]
C0004096
participant must have an asthma control questionnaire 6 (acq6) less than (<) 1.5 at screening
Beschrijving

Asthma control questionnaire

Datatype

boolean

Alias
UMLS CUI [1]
C2919686
* for participants with atopic dermatitis:
Beschrijving

Study Subject | Dermatitis, Atopic

Datatype

boolean

Alias
UMLS CUI [1]
C0681850
UMLS CUI [2]
C0011615
participant must have a physician documented diagnosis of atopic dermatitis for at least 12 months before screening based on uk refinement of the hanifin and rajka's diagnostic criteria
Beschrijving

Dermatitis, Atopic

Datatype

boolean

Alias
UMLS CUI [1]
C0011615
participant must have atopic dermatitis with and investigators global assessment (iga) score of 2 to 4 at screening
Beschrijving

Dermatitis, Atopic | Assessment scale Clinical Investigators

Datatype

boolean

Alias
UMLS CUI [1]
C0011615
UMLS CUI [2,1]
C0450973
UMLS CUI [2,2]
C0008961
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
participant has taken any prohibited or restricted medications as noted below under prestudy and concomitant therapy
Beschrijving

Drugs, Non-Prescription | Pre-study Therapeutic procedure | Concomitant Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0013231
UMLS CUI [2,1]
C1527048
UMLS CUI [2,2]
C0087111
UMLS CUI [3]
C1707479
participant has received an investigational drug (including investigational vaccines) or used an invasive investigational medical device within 6 weeks or 5 half-lives (whichever is longer) before the screening visit
Beschrijving

Investigational New Drugs | INVESTIGATIONAL VACCINES | Investigational Medical Device

Datatype

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C1875384
UMLS CUI [3]
C2346570
* for participants with asthma:
Beschrijving

Study Subject | Asthma

Datatype

boolean

Alias
UMLS CUI [1]
C0681850
UMLS CUI [2]
C0004096
participant has a history of life-threatening asthma, defined as a history of respiratory arrest or requiring intubation for asthma
Beschrijving

Asthma Life Threatening | Respiratory arrest | Requirement Intubation Asthma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
UMLS CUI [2]
C0162297
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0021925
UMLS CUI [3,3]
C0004096
participant had been admitted to a hospital for asthma in the 1 year before screening
Beschrijving

Hospitalization Asthma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0004096
* for participants with atopic dermatitis:
Beschrijving

Study Subject | Dermatitis, Atopic

Datatype

boolean

Alias
UMLS CUI [1]
C0681850
UMLS CUI [2]
C0011615
participant has evidence of any other skin condition that would interfere with assessment of atopic dermatitis (ad)
Beschrijving

Other Skin condition Interferes with Evaluation Atopic Dermatitis

Datatype

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C1719933
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C1261322
UMLS CUI [1,5]
C0011615
participant has active ad related infection or has had an active ad infection within 2 weeks of screening (participants with evidence of colonization on skin swab testing but with no infection are allowed)
Beschrijving

Atopic Dermatitis Related Communicable Disease | Skin swab (lab test)

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011615
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0009450
UMLS CUI [2]
C2266652
Terug naar het begin van de pagina

Similar models

Eligibility Dermatitis, Atopic NCT02343783

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent | Comprehension Study Protocol
Item
participant must have signed an informed consent document prior to any study related procedures indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study
boolean
C0021430 (UMLS CUI [1])
C0162340 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Compliance behavior Study Protocol
Item
participant must be willing/able to adhere to the study visit schedule and other requirements, prohibitions and restrictions specified in this protocol
boolean
C1321605 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Study Subject | Asthma
Item
* for participants with asthma:
boolean
C0681850 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
Asthma
Item
participant must have a physician documented diagnosis of asthma for at least 12 months before screening
boolean
C0004096 (UMLS CUI [1])
Asthma control questionnaire
Item
participant must have an asthma control questionnaire 6 (acq6) less than (<) 1.5 at screening
boolean
C2919686 (UMLS CUI [1])
Study Subject | Dermatitis, Atopic
Item
* for participants with atopic dermatitis:
boolean
C0681850 (UMLS CUI [1])
C0011615 (UMLS CUI [2])
Dermatitis, Atopic
Item
participant must have a physician documented diagnosis of atopic dermatitis for at least 12 months before screening based on uk refinement of the hanifin and rajka's diagnostic criteria
boolean
C0011615 (UMLS CUI [1])
Dermatitis, Atopic | Assessment scale Clinical Investigators
Item
participant must have atopic dermatitis with and investigators global assessment (iga) score of 2 to 4 at screening
boolean
C0011615 (UMLS CUI [1])
C0450973 (UMLS CUI [2,1])
C0008961 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Drugs, Non-Prescription | Pre-study Therapeutic procedure | Concomitant Therapy
Item
participant has taken any prohibited or restricted medications as noted below under prestudy and concomitant therapy
boolean
C0013231 (UMLS CUI [1])
C1527048 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C1707479 (UMLS CUI [3])
Investigational New Drugs | INVESTIGATIONAL VACCINES | Investigational Medical Device
Item
participant has received an investigational drug (including investigational vaccines) or used an invasive investigational medical device within 6 weeks or 5 half-lives (whichever is longer) before the screening visit
boolean
C0013230 (UMLS CUI [1])
C1875384 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
Study Subject | Asthma
Item
* for participants with asthma:
boolean
C0681850 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
Asthma Life Threatening | Respiratory arrest | Requirement Intubation Asthma
Item
participant has a history of life-threatening asthma, defined as a history of respiratory arrest or requiring intubation for asthma
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0162297 (UMLS CUI [2])
C1514873 (UMLS CUI [3,1])
C0021925 (UMLS CUI [3,2])
C0004096 (UMLS CUI [3,3])
Hospitalization Asthma
Item
participant had been admitted to a hospital for asthma in the 1 year before screening
boolean
C0019993 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Study Subject | Dermatitis, Atopic
Item
* for participants with atopic dermatitis:
boolean
C0681850 (UMLS CUI [1])
C0011615 (UMLS CUI [2])
Other Skin condition Interferes with Evaluation Atopic Dermatitis
Item
participant has evidence of any other skin condition that would interfere with assessment of atopic dermatitis (ad)
boolean
C0205394 (UMLS CUI [1,1])
C1719933 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C1261322 (UMLS CUI [1,4])
C0011615 (UMLS CUI [1,5])
Atopic Dermatitis Related Communicable Disease | Skin swab (lab test)
Item
participant has active ad related infection or has had an active ad infection within 2 weeks of screening (participants with evidence of colonization on skin swab testing but with no infection are allowed)
boolean
C0011615 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0009450 (UMLS CUI [1,3])
C2266652 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial